Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$27.01 - $40.26 $89,133 - $132,858
-3,300 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$27.75 - $43.44 $294,150 - $460,464
-10,600 Reduced 76.26%
3,300 $122,000
Q1 2020

May 15, 2020

BUY
$21.5 - $54.2 $105,350 - $265,580
4,900 Added 54.44%
13,900 $450,000
Q4 2019

Feb 14, 2020

BUY
$34.54 - $44.87 $310,860 - $403,830
9,000 New
9,000 $369,000
Q4 2018

Feb 14, 2019

SELL
$39.11 - $75.15 $101,686 - $195,390
-2,600 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$65.0 - $82.15 $968,500 - $1.22 Million
-14,900 Reduced 85.14%
2,600 $196,000
Q2 2018

Aug 14, 2018

BUY
$27.2 - $74.35 $476,000 - $1.3 Million
17,500 New
17,500 $1.26 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $340M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.